General Information of Drug (ID: DMZXT34)

Drug Name
(R)-2-amino-3-(4-octylphenylamino)propan-1-ol
Synonyms CHEMBL572686; (R)-2-amino-3-(4-octylphenylamino)propan-1-ol; SCHEMBL1312243
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 1 Molecular Weight (mw) 278.4
Logarithm of the Partition Coefficient (xlogp) 4.9
Rotatable Bond Count (rotbonds) 11
Hydrogen Bond Donor Count (hbonddonor) 3
Hydrogen Bond Acceptor Count (hbondacc) 3
Chemical Identifiers
Formula
C17H30N2O
IUPAC Name
(2R)-2-amino-3-(4-octylanilino)propan-1-ol
Canonical SMILES
CCCCCCCCC1=CC=C(C=C1)NC[C@H](CO)N
InChI
InChI=1S/C17H30N2O/c1-2-3-4-5-6-7-8-15-9-11-17(12-10-15)19-13-16(18)14-20/h9-12,16,19-20H,2-8,13-14,18H2,1H3/t16-/m1/s1
InChIKey
RCARSJSFSXRXLF-MRXNPFEDSA-N
Cross-matching ID
PubChem CID
45255203
ChEBI ID
CHEMBL572686
TTD ID
D0E3LA
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Sphingosine kinase 2 (SPHK2) TTCN0M9 SPHK2_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Discovery of novel sphingosine kinase 1 inhibitors. Bioorg Med Chem Lett. 2009 Nov 1;19(21):6119-21.